As filed with the Securities and Exchange Commission on July 24, 2025
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER THE
SECURITIES ACT OF 1933
Carlsmed, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
83-1081863 |
(State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification Number) |
|
|
1800 Aston Ave, Suite 100 Carlsbad, California |
92008 |
(Address of principal executive offices) |
(Zip code) |
Carlsmed, Inc. 2019 Stock Incentive Plan
Carlsmed, Inc. 2025 Equity Incentive Plan
Carlsmed, Inc. 2025 Employee Stock Purchase Plan
(Full title of the plan)
Michael Cordonnier
Chairman, Chief Executive Officer, President and Co-Founder
Carlsmed, Inc.
1800 Aston Ave, Suite 100
Carlsbad, California 92008
(Name and address of agent for service)
(760) 766-1923
(Telephone number, including area code, of agent for service)
Copies to:
R. John Hensley
H. Thomas Felix
James M. Krenn
Morrison & Foerster LLP
12531 High Bluff Drive, Suite 200
San Diego, California 92130
(858) 720-5100
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
☐ |
Accelerated filer |
☐ |
|
|
|
|
Non-accelerated filer |
☒ |
Smaller reporting company |
☒ |
|
|
|
|
|
|
Emerging growth company |
☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☒